Ostrovskaya RU - Search Results

1

Low molecular weight NGF mimetic GK-2 normalizes the parameters of glucose and lipid metabolism and exhibits a hepatoprotective effect on a prediabetes model in obese Wistar rats.

Ivanov SV, Ostrovskaya RU, Koliasnikova KN, Alchinova IB, Demorzhi MS, Gudasheva TA, Seredenin SB. Ivanov SV, et al. Among authors: ostrovskaya ru. Clin Exp Pharmacol Physiol. 2022 Oct;49(10):1116-1125. doi: 10.1111/1440-1681.13693. Epub 2022 Jul 12. Clin Exp Pharmacol Physiol. 2022. PMID: 35748804

2

Neuroprotective Substances: Are they Able to Protect the Pancreatic Beta- Cells Too?

Ostrovskaya RU, Ivanov SV. Ostrovskaya RU, et al. Endocr Metab Immune Disord Drug Targets. 2022;22(8):834-841. doi: 10.2174/1871530322666220303162844. Endocr Metab Immune Disord Drug Targets. 2022. PMID: 35240968 Review.

3

A Novel Dipeptide NGF Mimetic GK-2 Selectively Activating the PI3K/AKT Signaling Pathway Promotes the Survival of Pancreatic β-Cells in a Rat Model of Diabetes.

Ostrovskaya RU, Ivanov SV, Gudasheva TA, Seredenin SB. Ostrovskaya RU, et al. Acta Naturae. 2019 Jan-Mar;11(1):48-57. Acta Naturae. 2019. PMID: 31024748 Free PMC article.

4

The PI3K/Akt Cascade Is Involved in the Antidiabetic Effect of Compound GSB-214, a Low-Molecular-Weight BDNF Mimetic.

Yagubova SS, Ostrovskaya RU, Gudasheva TA, Seredenin SB. Yagubova SS, et al. Among authors: ostrovskaya ru. Bull Exp Biol Med. 2020 Oct;169(6):771-774. doi: 10.1007/s10517-020-04975-7. Epub 2020 Oct 24. Bull Exp Biol Med. 2020. PMID: 33123919

5

Low-Molecular-Weight Perorally Active Nerve Growth Factor Mimetic Reduces Manifestations of Diabetic Neuropathy in Wistar Rats.

Ivanov SV, Ostrovskaya RU, Khlybova AS, Gudasheva TA. Ivanov SV, et al. Among authors: ostrovskaya ru. Bull Exp Biol Med. 2022 May;173(1):37-40. doi: 10.1007/s10517-022-05488-1. Epub 2022 May 27. Bull Exp Biol Med. 2022. PMID: 35622256

6

Dimeric NGF Mimetic Attenuates Hyperglycaemia and DNA Damage in Mice with Streptozotocin-Induced Early-Stage Diabetes.

Yagubova S, Zhanataev A, Ostrovskaya R, Anisina Е, Gudasheva Т, Durnev А, Seredenin S. Yagubova S, et al. Endocr Metab Immune Disord Drug Targets. 2020;20(3):453-463. doi: 10.2174/1871530319666190806115623. Endocr Metab Immune Disord Drug Targets. 2020. PMID: 31385776

7

The novel substituted acylproline-containing dipeptide, GVS-111, promotes the restoration of learning and memory impaired by bilateral frontal lobectomy in rats.

Ostrovskaya RU, Romanova GA, Trofimov SS, Gudasheva TA, Voronina TA, Halikas JA, Seredenin SB. Ostrovskaya RU, et al. Behav Pharmacol. 1997 Jun;8(2-3):261-8. Behav Pharmacol. 1997. PMID: 9833021

8

Noopept stimulates the expression of NGF and BDNF in rat hippocampus.

Ostrovskaya RU, Gudasheva TA, Zaplina AP, Vahitova JV, Salimgareeva MH, Jamidanov RS, Seredenin SB. Ostrovskaya RU, et al. Bull Exp Biol Med. 2008 Sep;146(3):334-7. doi: 10.1007/s10517-008-0297-x. Bull Exp Biol Med. 2008. PMID: 19240853

9

Antidiabetic activity of a novel dipeptide mimetic of nerve growth factor.

Povarnina PY, Ozerova IV, Ostrovskaya RU, Gudasheva TA, Seredenin SB. Povarnina PY, et al. Among authors: ostrovskaya ru. Dokl Biol Sci. 2013 Mar;449:76-8. doi: 10.1134/S001249661302004X. Epub 2013 May 8. Dokl Biol Sci. 2013. PMID: 23652431 No abstract available.

10

Original Nerve Growth Factor Mimetic Dipeptide GK-2 Restores Impaired Cognitive Functions in Rat Models of Alzheimer's Disease.

Povarnina PY, Vorontsova ON, Gudasheva TA, Ostrovskaya RU, Seredenin SB. Povarnina PY, et al. Among authors: ostrovskaya ru. Acta Naturae. 2013 Jul;5(3):84-91. Acta Naturae. 2013. PMID: 24303204 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

67 results

Search Page